The current BEAM market cap is 1.97B. The company's latest EPS is USD -1.6230 and P/E is -14.85.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 15.8M | 20.04M | 24.21M | 20.12M | 17.19M |
Operating Income | -91.3M | -68.79M | -98.93M | -102.15M | -108.27M |
Net Income | -109.58M | -38.35M | -96.46M | -82.78M | -96.09M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 18k | 24k | 51.84M | 60.92M | 377.71M |
Operating Income | -75.15M | -132.76M | -392.47M | -318.28M | -176.49M |
Net Income | -91.04M | -194.59M | -370.64M | -289.09M | -132.53M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.35B | 1.34B | 1.33B | 1.35B | 1.29B |
Total Liabilities | 635.77M | 608.24M | 570.85M | 542.24M | 511.59M |
Total Equity | 714.48M | 733.47M | 761.51M | 811.64M | 778.94M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 156.1M | 451.68M | 1.47B | 1.34B | 1.46B |
Total Liabilities | 55.15M | 206.12M | 647.72M | 608.24M | 478.39M |
Total Equity | -201.1M | 245.56M | 826.74M | 733.47M | 981.33M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 91.72M | 22.53M | -109.82M | -194.48M | -284.27M |
Investing | -574.78M | -461.34M | 25.45M | -16.03M | -26.26M |
Financing | 79.58M | 111.59M | 98.42M | 205.96M | 242.74M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -72M | -95.74M | -66.27M | 22.53M | -149.2M |
Investing | -66.66M | -100.12M | -294.14M | -461.34M | 71.84M |
Financing | 41.28M | 322.32M | 756.14M | 111.59M | 276.45M |
Market Cap | 1.97B |
Price to Earnings Ratio | -14.85 |
Price to Sales Ratio | 5.21 |
Price to Cash Ratio | 4.51 |
Price to Book Ratio | 2.01 |
Dividend Yield | - |
Shares Outstanding | 81.66M |
Average Volume (1 week) | 2.36M |
Average Volume (1 Month) | 1.61M |
52 Week Change | -22.66% |
52 Week High | 49.50 |
52 Week Low | 16.95 |
Spread (Intraday) | 0.08 (0.33%) |
Company Name | Beam Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.beamtx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.